MEWIGEN Liquid Biopsy
Please find our cfDNA analysis services below
MEWIGEN offers the NGS-based detection of somatic markers from blood plasma samples. This enables the sampling of information for further therapy planning in a non-invasive way.
| Gene | Mutations | Exons | |
| EGFR | activating mutations | 18 – 21 | NM_005228.5 c.2062-2625, p.688-875 |
| PIK3CA | activating mutations | 8, 10 and 21 | NM_006218.4 c.1252-1404, p.419-469 (E8) c.1540-1664, p.514-555 (E10) c.2937-3207, p.979-* (E21) |
| PIK3CA | E542K, E545K, H1047R/L | Targeted examination | NM_006218.4 c.1624G>A NM_006218.4 c.1633G>A NM_006218.4 c.3140A>G / c.3140A>T |
Method:
NGS
Turnaround time:
6 weeks
Specimen requirements:
10 ml blood sample collected in cfDNA stabilizing tubes like Streck or PaxGene tubes